Comprehensive Patient Care in BRG Clinical Trials
The safety of clinical trial participants is the foundation of our operations. At BRG, comprehensive patient care is not an addition — it is the standard.
Participation in a clinical trial may involve health risks for the patient. Therefore, before the study begins, each patient receives detailed information regarding the course of the study, its potential benefits, and possible adverse events. The decision to participate is always voluntary and made consciously.

During the study, the patient:
-
remains under the continuous care of a qualified medical team,
-
has direct contact with the Principal Investigator,
-
is regularly monitored in accordance with the study protocol and applicable standards,
-
may report any concerning symptoms at any time.
We ensure full medical care both during the study and in the event of any health problems occurring after the study. Every patient report is treated with the utmost attention, and appropriate actions are taken immediately in accordance with applicable safety procedures.
News
Increasing Access to Breakthrough Clinical Trials for Patients in Poland
Read more … Increasing Access to Breakthrough Clinical Trials for Patients in Poland
Clinical research reshapes nicotine regulation – new publication by BRG CEO
Read more … Clinical research reshapes nicotine regulation – new publication by BRG CEO
BRG’s Contribution to the Advancement of an Innovative Therapy
Read more … BRG’s Contribution to the Advancement of an Innovative Therapy




